This week’s healthcare headlines: Focus on Novo Nordisk, Bristol-Myers, and J&J

Key events include the launch of direct-to-consumer drug platforms linked to the Trump family, court rulings against Novo Nordisk over Medicare negotiations, the massive jury award against Johnson & Johnson, UnitedHealth’s acquisition of a primary care group, Novo Nordisk’s acquisition of Acero Therapeutics, and Bristol-Myers Squibb’s purchase of Orbital Therapeutics.